Related references
Note: Only part of the references are listed.Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options
Camille Tlemsani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Prognostic Significance of Percentage and Size of Dedifferentiation in Dedifferentiated Chondrosarcoma
Yin P. Hung et al.
MODERN PATHOLOGY (2023)
EZH2/hSULF1 axis mediates receptor tyrosine kinase signaling to shape cartilage tumor progression
Zong-Shin Lin et al.
ELIFE (2023)
Chondrosarcoma: A Clinical Review
Aaron Gazendam et al.
JOURNAL OF CLINICAL MEDICINE (2023)
Chondrosarcoma Resistance to Radiation Therapy: Origins and Potential Therapeutic Solutions
Antoine Gilbert et al.
CANCERS (2023)
A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma
Nam Bui et al.
CANCERS (2023)
Molecular In-Depth Characterization of Chondrosarcoma for Current and Future Targeted Therapies
Sebastian Gottfried Walter et al.
CANCERS (2023)
Classification of Chondrosarcoma: From Characteristic to Challenging Imaging Findings
Jun-Ho Kim et al.
CANCERS (2023)
Distinct IDH1/2-associated Methylation Profile and Enrichment of TP53 and TERT Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma
Josephine Kam Tai Dermawan et al.
CANCER RESEARCH COMMUNICATIONS (2023)
Is Chemotherapy Associated with Improved Overall Survival in Patients with Dedifferentiated Chondrosarcoma? A SEER Database Analysis
Lee D. Cranmer et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2022)
Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma
Shinji Miwa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi-institutional study
Eiji Kozawa et al.
CANCER SCIENCE (2022)
Prognostic impact of IDH mutations in chondrosarcoma
Makoto Nakagawa et al.
JOURNAL OF ORTHOPAEDIC SCIENCE (2022)
Image-guided core needle biopsy for musculoskeletal lesions
Shunichi Toki et al.
JOURNAL OF ORTHOPAEDIC SCIENCE (2022)
Clinical usefulness of 2-hydroxyglutarate as a biomarker in IDH-mutant chondrosarcoma
Makoto Nakagawa et al.
JOURNAL OF BONE ONCOLOGY (2022)
Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas
Victor Albarran et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Case report: Treatment of metastatic dedifferentiated chondrosarcoma with pembrolizumab yields sustained complete response
Amisha Singh et al.
FRONTIERS IN ONCOLOGY (2022)
Appendicular dedifferentiated chondrosarcoma: A management and survival study from the SEER database
Marcos R. Gonzalez et al.
JOURNAL OF BONE ONCOLOGY (2022)
Mice with Trp53 and Rb1 deficiency in chondrocytes spontaneously develop chondrosarcoma via overactivation of YAP signaling
Yang Li et al.
CELL DEATH & DISEASE (2022)
Recent advances of IDH1 mutant inhibitor in cancer therapy
Wangqi Tian et al.
FRONTIERS IN PHARMACOLOGY (2022)
Dedifferentiated Chondrosarcoma: A Case Series and Review of the Literature
Charles A. Gusho et al.
ORTHOPEDIC REVIEWS (2022)
Evaluation of prognostic factors affecting survival in chondrosarcoma treatment and comparison with literature
Huseyin Sina Coskun et al.
JOINT DISEASES AND RELATED SURGERY (2022)
Pathological fracture does not affect prognosis in dedifferentiated chondrosarcoma of the limbs
Andrea Sambri et al.
JOURNAL OF ORTHOPAEDIC SCIENCE (2021)
Dedifferentiated chondrosarcoma: current standards of care
Abhay K. Kattepur et al.
FUTURE ONCOLOGY (2021)
NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study
Madiha Syed et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2021)
Metabolic Pathways and Targets in Chondrosarcoma
Ida Micaily et al.
FRONTIERS IN ONCOLOGY (2021)
Chondrosarcoma-from Molecular Pathology to Novel Therapies
Agnieszka E. Zajac et al.
CANCERS (2021)
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
Ivar Hompland et al.
EUROPEAN JOURNAL OF CANCER (2021)
Prognostic importance of IDH mutations in chondrosarcoma: An individual patient data meta-analysis
Huy Gia Vuong et al.
CANCER MEDICINE (2021)
Dedifferentiated Central Chondrosarcoma: A Clinical, Histopathological, and Immunohistochemical Analysis of 57 Cases
Li-Hua Gong et al.
FRONTIERS IN MEDICINE (2021)
Targeted Next-Generation Sequencing Identifies Molecular and Genetic Events in Dedifferentiated Chondrosarcoma
Calixto-Hope G. Lucas et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2021)
The incidence and diagnostic relevance of pathological fracture in conventional central chondrosarcoma
Abdulaziz Alqubaisi et al.
SKELETAL RADIOLOGY (2021)
Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database Analysis
Kamil M. Amer et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2020)
The immune landscape of chondrosarcoma - potential for therapeutic targeting of CSFR1+macrophages
Iseulys Richert et al.
JOURNAL OF BONE ONCOLOGY (2020)
Natural history of Ollier disease and Maffucci syndrome: Patient survey and review of clinical literature
Jad M. El Abiad et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2020)
IDH mutation in glioma: molecular mechanisms and potential therapeutic targets
Sue Han et al.
BRITISH JOURNAL OF CANCER (2020)
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma
William D. Tap et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
IMMUNOSARC: a collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I/II trial of sunitinib and nivolumab in advanced soft tissue and bone sarcoma: Results from the phase II part, bone sarcoma cohort.
Emanuela Palmerini et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Ivosidenib in IDH1-mutant, chemotherapy-refractory Croatia& cholangiocarcinoma (ClarlDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
Clonality analysis and IDH1 and IDH2 mutation detection in both components of dedifferentiated chondrosarcoma, implicated its monoclonal origin
Tingting Yang et al.
JOURNAL OF BONE ONCOLOGY (2020)
Treatment method and prognostic factors of chondrosarcoma: based on Surveillance, Epidemiology, and End Results (SEER) database
Kun-Chi Hua et al.
TRANSLATIONAL CANCER RESEARCH (2020)
Skull Base Chordomas and Chondrosarcomas
Natalia Kremenevski et al.
NEUROENDOCRINOLOGY (2020)
Beyond the Influence of IDH Mutations: Exploring Epigenetic Vulnerabilities in Chondrosarcoma
Sanne Venneker et al.
CANCERS (2020)
Mutant p53 in Cancer Progression and Targeted Therapies
Gaoyang Zhu et al.
FRONTIERS IN ONCOLOGY (2020)
Successful treatment of a dedifferentiated chondrosarcoma of the proximal humerus with a hemicortical articular surface sparing allograft: A case report
Charles D. Gomez et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2020)
Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma
Annemiek van Maldegem et al.
ONCOLOGIST (2019)
IDH mutation status in a series of 88 head and neck chondrosarcomas: different profile between tumors of the skull base and tumors involving the facial skeleton and the laryngotracheal tract
Matthias Tallegas et al.
HUMAN PATHOLOGY (2019)
An update on current and future treatment options for chondrosarcoma
Iona J. MacDonald et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2019)
Integrated molecular characterization of chondrosarcoma reveals critical determinants of disease progression
Remy Nicolle et al.
NATURE COMMUNICATIONS (2019)
Coexistence of secondary chondrosarcoma and lung carcinoma metastasis in the humerus of a patient with Ollier's disease: A case report
Osman Emre Aycan et al.
ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA (2019)
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study
Florence Duffaud et al.
LANCET ONCOLOGY (2019)
H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features
Naohiro Makise et al.
MODERN PATHOLOGY (2019)
Risk Factors for Incidence and Prognosis in Chondrosarcoma Patients with Pulmonary Metastasis at Initial Diagnosis
Minh Tien Nguyen et al.
MEDICAL SCIENCE MONITOR (2019)
New TNM classification (AJCC eighth edition) of bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group
Kazuhiro Tanaka et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2019)
The role of surgical margins in chondrosarcoma
Jonathan D. Stevenson et al.
EJSO (2018)
Mesenchymal chondrosarcomas showing immunohistochemical evidence of rhabdomyoblastic differentiation: a potential diagnostic pitfall
Andrew L. Folpe et al.
HUMAN PATHOLOGY (2018)
Biomarkers of chondrosarcoma
Wonju Jeong et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
Incidence, outcomes and prognostic factors during 25 years of treatment of chondrosarcomas
V. M. van Praag (Veroniek) et al.
SURGICAL ONCOLOGY-OXFORD (2018)
IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma
Iwona Lugowska et al.
JOURNAL OF CANCER (2018)
Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets
Elahe Nazeri et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Response to PD1 inhibition in conventions chondrosarcoma
Michael J. Wagner et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Dedifferentiated chondrosarcoma of the pelvis: clinical outcomes and current treatment
Johnathan R. Lex et al.
CLINICAL SARCOMA RESEARCH (2018)
Phase 2 Study of Dasatinib in Patients With Alveolar Soft Part Sarcoma, Chondrosarcoma, Chordoma, Epithelioid Sarcoma, or Solitary Fibrous Tumor
Scott M. Schuetze et al.
CANCER (2017)
Description of the immune microenvironment of chondrosarcoma and contribution to progression
Francois A. Simard et al.
ONCOIMMUNOLOGY (2017)
Novel therapeutic approaches in chondrosarcoma
Genovefa Polychronidou et al.
FUTURE ONCOLOGY (2017)
Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone
Shaoxiong Chen et al.
HUMAN PATHOLOGY (2017)
Immunohistochemical Validation of Spontaneously Arising Canine Osteosarcoma as a Model for Human Osteosarcoma
A. A. Al-Khan et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2017)
Dedifferentiated chondrosarcoma: A survival analysis of 159 cases from the SEER database (2001-2011)
Patrick K. Strotman et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
NCCN Guidelines® Insights Bone Cancer, Version 2.2017 Featured Updates to the NCCN Guidelines
J. Sybil Biermann et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi et al.
LANCET ONCOLOGY (2017)
Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets and strategies
Daniela Augsburger et al.
ONCOTARGET (2017)
Dedifferentiated chondrosarcoma: Radiological features, prognostic factors and survival statistics in 23 patients
Chenglei Liu et al.
PLOS ONE (2017)
Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtype
Marie Kostine et al.
MODERN PATHOLOGY (2016)
Targeted next-generation sequencing of dedifferentiated chondrosarcoma in the skull base reveals combined TP53 and PTEN mutations with increased proliferation index, an implication for pathogenesis
Lu Gao et al.
ONCOTARGET (2016)
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
Pratistha Koirala et al.
SCIENTIFIC REPORTS (2016)
Coexistence of her2, ki67, and p53 in osteosarcoma: A strong prognostic factor
Keykhosro Mardanpour et al.
NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES (2016)
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
L. Paoluzzi et al.
CLINICAL SARCOMA RESEARCH (2016)
The Role of Immunohistochemistry in Rhabdomyosarcoma Diagnosis Using Tissue Microarray Technology and a Xenograft Model
Isidro Machado et al.
FETAL AND PEDIATRIC PATHOLOGY (2015)
Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment
Sandra P. D'Angelo et al.
HUMAN PATHOLOGY (2015)
Management and prognostic significance of pathological fractures through chondrosarcoma of the femur
Jose I. Albergo et al.
INTERNATIONAL ORTHOPAEDICS (2015)
The Epigenetic Regulation of SOX9 by miR-145 in Human Chondrosarcoma
Isabella W. Y. Mak et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
NY-ESO-1 (CTAG1B) expression in mesenchymal tumors
Makoto Endo et al.
MODERN PATHOLOGY (2015)
Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas
M. Fernanda Amary et al.
VIRCHOWS ARCHIV (2015)
Does Ifosfamide Therapy Improve Survival of Patients With Dedifferentiated Chondrosarcoma?
Satoshi Kawaguchi et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2014)
The molecular pathogenesis of dedifferentiated chondrosarcoma
Akio Sakamoto
INDIAN JOURNAL OF ORTHOPAEDICS (2014)
Radiation-Induced Dedifferentiated Chondrosarcoma With Orbital Invasion
Brett W. Davies et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2014)
Dedifferentiated chondrosarcoma mimicking a giant cell tumor. Is this low grade dedifferentiated chondrosarcoma?
Thomas Knoesel et al.
PATHOLOGY RESEARCH AND PRACTICE (2014)
Screening for Potential Targets for Therapy in Mesenchymal, Clear Cell, and Dedifferentiated Chondrosarcoma Reveals Bcl-2 Family Members and TGFβ as Potential Targets
Jolieke G. van Oosterwijk et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Cell Cycle Regulatory Markers in Uterine Atypical Leiomyoma and Leiomyosarcoma Immunohistochemical Study of 68 Cases With Clinical Follow-up
Anne M. Mills et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study
A. Italiano et al.
ANNALS OF ONCOLOGY (2013)
Advanced chondrosarcomas: role of chemotherapy and survival
A. Italiano et al.
ANNALS OF ONCOLOGY (2013)
Functional Profiling of Receptor Tyrosine Kinases and Downstream Signaling in Human Chondrosarcomas Identifies Pathways for Rational Targeted Therapy
Yi-Xiang Zhang et al.
CLINICAL CANCER RESEARCH (2013)
Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma
Patrick S. Tarpey et al.
NATURE GENETICS (2013)
Tumor Infiltrating PD1-Positive Lymphocytes and the Expression of PD-L1 Predict Poor Prognosis of Soft Tissue Sarcomas
Jung Ryul Kim et al.
PLOS ONE (2013)
The imaging of cartilaginous bone tumours. II. Chondrosarcoma
H. Douis et al.
SKELETAL RADIOLOGY (2013)
MDM2 and CDK4 lmmunohistochemical Coexpression in High-grade Osteosarcoma: Correlation With a Dedifferentiated Subtype
Akihiko Yoshida et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Clinical activity of mTOR inhibition in combination with cyclophosphamide in the treatment of recurrent unresectable chondrosarcomas
Rinat Bernstein-Molho et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma
Danielle Meijer et al.
GENES CHROMOSOMES & CANCER (2012)
Primary Chondrosarcoma of Male Breast: A Rare Case
Rama Kumari Badyal et al.
INDIAN JOURNAL OF SURGERY (2012)
The treatment of locally recurrent chondrosarcoma IS EXTENSIVE FURTHER SURGERY JUSTIFIED?
A. Streitbuerger et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2012)
NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis
Jin-Ping Lai et al.
MODERN PATHOLOGY (2012)
Dedifferentiated peripheral chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of four cases
Alessandro Franchi et al.
VIRCHOWS ARCHIV (2012)
Clinical outcome for patients with dedifferentiated chondrosarcoma: a report of 9 cases at a single institute
Kazuya Yokota et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2012)
Sox10 and S100 in the Diagnosis of Soft-tissue Neoplasms
Jason R. Karamchandani et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)
Revisiting CT-Guided Percutaneous Core Needle Biopsy of Musculoskeletal Lesions: Contributors to Biopsy Success
Michelle C. Omura et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
A Phase 2 Trial of Imatinib Mesylate in Patients With Recurrent Nonresectable Chondrosarcomas Expressing Platelet-Derived Growth Factor Receptor-α or -β An Italian Sarcoma Group Study
Giovanni Grignani et al.
CANCER (2011)
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
M. Fernanda Amary et al.
JOURNAL OF PATHOLOGY (2011)
Diagnosis of a Dedifferentiated Chondrosarcoma of the Pelvis by Fine Needle Aspiration A Case Report
Erendira Estrada-Villasenor et al.
ACTA CYTOLOGICA (2010)
Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases
Julie C. Fanburg-Smith et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2010)
Different expression of Sox9 and Runx2 between chondrosarcoma and dedifferentiated chondrosarcoma cell line
Xiaodong Tang et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2010)
Matrix biochemistry and cell biology of dedifferentiated chondrosarcomas
Kerstin Dornauer et al.
PATHOLOGY INTERNATIONAL (2010)
Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40
Soren Daugaard et al.
APMIS (2009)
Cluster Analysis of Immunohistochemical Markers in Leiomyosarcoma Delineates Specific Anatomic and Gender Subgroups
Jason C. Carvalho et al.
CANCER (2009)
Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment
Yvonne M. Schrage et al.
CANCER RESEARCH (2009)
A novel mutated cell line with characteristics of dedifferentiated chondrosarcoma
Liye Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2009)
Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes
Leida B. Rozeman et al.
MODERN PATHOLOGY (2009)
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Pelvic chondrosarcomas: Surgical treatment options
X. Deloin et al.
ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH (2009)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis
Gerard J. Oakley et al.
MODERN PATHOLOGY (2008)
The clinical approach towards chondrosarcoma
Hans Gelderblom et al.
ONCOLOGIST (2008)
Dedifferentiated chondrosarcoma: Prognostic factors and outcome from a European group
Robert J. Grimer et al.
EUROPEAN JOURNAL OF CANCER (2007)
Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases
Thomas Mentzel et al.
VIRCHOWS ARCHIV (2006)
Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry
M Wachtel et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Dedifferentiated chondrosarcoma - a fatal disease
J Bruns et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
Accuracy of computed tomography guided core needle biopsy of musculoskeletal tumours
AO Altuntas et al.
ANZ JOURNAL OF SURGERY (2005)
Use of alkaline phosphatase staining to differentiate canine osteosarcoma from other vimentin-positive tumors
A Barger et al.
VETERINARY PATHOLOGY (2005)
Dedifferentiated chondrosarcoma: use of MRI to guide needle biopsy
A Saifuddin et al.
CLINICAL RADIOLOGY (2004)
Radiographic, CT, and MR imaging features of differentiated chondrosarcomas: A retrospective review of 174 de novo cases
LA Littrell et al.
RADIOGRAPHICS (2004)
Genetics of chondrosarcoma and related tumors
AA Sandberg
CURRENT OPINION IN ONCOLOGY (2004)
Dedifferentiated chondrosarcoma: The role of chemotherapy with updated outcomes
ID Dickey et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2004)
Clinicopathological and immunohistochemical analysis of twenty-five head and neck osteosarcomas
D Takahama et al.
ORAL ONCOLOGY (2003)
Immunohistochemistry in the diagnosis of soft tissue tumours
JM Coindre
HISTOPATHOLOGY (2003)
Histology and immunohistochemistry of seven ferret vaccination-site fibrosarcomas
JS Munday et al.
VETERINARY PATHOLOGY (2003)
Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: A review of 25 cases initially diagnosed as malignant fibrous histiocytoma
JM Coindre et al.
MODERN PATHOLOGY (2003)
Genetic and epigenetic alterations in tumor progression in a dedifferentiated chondrosarcoma
M Ropke et al.
PATHOLOGY RESEARCH AND PRACTICE (2003)
Dedifferentiated chondrosarcoma of the appendicular skeleton: MRI-pathological correlation
F MacSweeney et al.
SKELETAL RADIOLOGY (2003)
Diagnosis of primary bone tumors with image-guided percutaneous biopsy: Experience with 110 tumors
JS Jelinek et al.
RADIOLOGY (2002)
The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
L Bingle et al.
JOURNAL OF PATHOLOGY (2002)
Pleomorphic leiomyosarcoma - Clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma
Y Oda et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Chromosomal changes in a dedifferentiated chondrosarcoma: a case report and review of the literature
DP O'Malley et al.
CANCER GENETICS AND CYTOGENETICS (2001)
Mutation of p53 with loss of heterozygosity in the osteosarcomatous component of a dedifferentiated chondrosarcoma
HJ Grote et al.
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2000)
Share Paper
